158 related articles for article (PubMed ID: 36768386)
1. Lycorine Carbamate Derivatives for Reversing P-glycoprotein-Mediated Multidrug Resistance in Human Colon Adenocarcinoma Cells.
Sancha SAR; Szemerédi N; Spengler G; Ferreira MU
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768386
[TBL] [Abstract][Full Text] [Related]
2. Lycorine and homolycorine derivatives for chemo-sensitizing resistant human ovarian adenocarcinoma cells.
Sancha SAR; Dobiasová S; Nejedlý T; Strnad O; Viktorová J; Ferreira MU
Phytomedicine; 2024 Apr; 126():155460. PubMed ID: 38394731
[TBL] [Abstract][Full Text] [Related]
3. Triterpenes from Momordica balsamina (African pumpkin): ABCB1 inhibition and synergistic interaction with doxorubicin in resistant cancer cells.
Silva CD; Ramalhete C; Spengler G; Mulhovo S; Molnar J; Ferreira MU
Phytochemistry; 2022 Nov; 203():113354. PubMed ID: 35940427
[TBL] [Abstract][Full Text] [Related]
4. Modulation of the spacer in N,N-bis(alkanol)amine aryl ester heterodimers led to the discovery of a series of highly potent P-glycoprotein-based multidrug resistance (MDR) modulators.
Dei S; Braconi L; Trezza A; Menicatti M; Contino M; Coronnello M; Chiaramonte N; Manetti D; Perrone MG; Romanelli MN; Udomtanakunchai C; Colabufo NA; Bartolucci G; Spiga O; Salerno M; Teodori E
Eur J Med Chem; 2019 Jun; 172():71-94. PubMed ID: 30947123
[TBL] [Abstract][Full Text] [Related]
5. Reversal of ABCB1-related Multidrug Resistance of Colonic Adenocarcinoma Cells by Phenothiazines.
Takács D; Csonka Á; Horváth Á; Windt T; Gajdács M; Riedl Z; Hajós G; Amaral L; Molnár J; Spengler G
Anticancer Res; 2015 Jun; 35(6):3245-51. PubMed ID: 26026084
[TBL] [Abstract][Full Text] [Related]
6. Exploring the Monoterpene Indole Alkaloid Scaffold for Reversing P-Glycoprotein-Mediated Multidrug Resistance in Cancer.
Cardoso DSP; Szemerédi N; Spengler G; Mulhovo S; Dos Santos DJVA; Ferreira MU
Pharmaceuticals (Basel); 2021 Aug; 14(9):. PubMed ID: 34577562
[TBL] [Abstract][Full Text] [Related]
7. Alkylated monoterpene indole alkaloid derivatives as potent P-glycoprotein inhibitors in resistant cancer cells.
Cardoso DSP; Kincses A; Nové M; Spengler G; Mulhovo S; Aires-de-Sousa J; Dos Santos DJVA; Ferreira MU
Eur J Med Chem; 2021 Jan; 210():112985. PubMed ID: 33189435
[TBL] [Abstract][Full Text] [Related]
8. Bipiperidinyl derivatives of 23-hydroxybetulinic acid reverse resistance of HepG2/ADM and MCF-7/ADR cells.
Zhang DM; Li YJ; Shu C; Ruan ZX; Chen WM; Yiu A; Peng YH; Wang J; Lan P; Yao Z; Fung KP; Fu LW; Chen ZS; Ye WC
Anticancer Drugs; 2013 Jun; 24(5):441-54. PubMed ID: 23466650
[TBL] [Abstract][Full Text] [Related]
9. New Chalcone Derivative Inhibits ABCB1 in Multidrug Resistant T-cell Lymphoma and Colon Adenocarcinoma Cells.
Čižmáriková M; Takáč P; Spengler G; Kincses A; Nové M; Vilková M; Mojžiš J
Anticancer Res; 2019 Dec; 39(12):6499-6505. PubMed ID: 31810914
[TBL] [Abstract][Full Text] [Related]
10. Reversal of P-glycoprotein-mediated multidrug resistance by natural N-alkylated indole alkaloid derivatives in KB-ChR-8-5 drug-resistant cancer cells.
Bharathiraja P; Cardoso DSP; Rajendra Prasad N; Mulhovo S; Lakra DS; Ferreira MU
J Biochem Mol Toxicol; 2023 Sep; 37(9):e23421. PubMed ID: 37345739
[TBL] [Abstract][Full Text] [Related]
11. Reversal effect of FW-04-806, a macrolide dilactone compound, on multidrug resistance mediated by ABCB1 and ABCG2 in vitro and in vivo.
Zhang Z; Ma C; Li P; Wu M; Ye S; Fu L; Xu J
Cell Commun Signal; 2019 Sep; 17(1):110. PubMed ID: 31472682
[TBL] [Abstract][Full Text] [Related]
12. 5-Oxo-hexahydroquinoline derivatives as modulators of P-gp, MRP1 and BCRP transporters to overcome multidrug resistance in cancer cells.
Ranjbar S; Khonkarn R; Moreno A; Baubichon-Cortay H; Miri R; Khoshneviszadeh M; Saso L; Edraki N; Falson P; Firuzi O
Toxicol Appl Pharmacol; 2019 Jan; 362():136-149. PubMed ID: 30391378
[TBL] [Abstract][Full Text] [Related]
13. Molecular design, synthesis and biological evaluation of novel 1,2,5-trisubstituted benzimidazole derivatives as cytotoxic agents endowed with ABCB1 inhibitory action to overcome multidrug resistance in cancer cells.
Abdelhafiz AHA; Serya RAT; Lasheen DS; Wang N; Sobeh M; Wink M; Abouzid KAM
J Enzyme Inhib Med Chem; 2022 Dec; 37(1):2710-2724. PubMed ID: 36168121
[TBL] [Abstract][Full Text] [Related]
14. Search for ABCB1 Modulators Among 2-Amine-5-Arylideneimidazolones as a New Perspective to Overcome Cancer Multidrug Resistance.
Kaczor A; Nové M; Kincses A; Spengler G; Szymańska E; Latacz G; Handzlik J
Molecules; 2020 May; 25(9):. PubMed ID: 32403277
[TBL] [Abstract][Full Text] [Related]
15. Polyaromatic alkaloids from marine invertebrates as cytotoxic compounds and inhibitors of multidrug resistance caused by P-glycoprotein.
Quesada AR; García Grávalos MD; Fernández Puentes JL
Br J Cancer; 1996 Sep; 74(5):677-82. PubMed ID: 8795567
[TBL] [Abstract][Full Text] [Related]
16. β-carotene reverses multidrug resistant cancer cells by selectively modulating human P-glycoprotein function.
Teng YN; Sheu MJ; Hsieh YW; Wang RY; Chiang YC; Hung CC
Phytomedicine; 2016 Mar; 23(3):316-23. PubMed ID: 26969385
[TBL] [Abstract][Full Text] [Related]
17. Reversing Multidrug Resistance in Chemo-resistant Human Lung Adenocarcinoma (A549/DOX) Cells by Algerian Propolis Through Direct Inhibiting the P-gp Efflux-pump, G0/G1 Cell Cycle Arrest and Apoptosis Induction.
Kebsa W; Lahouel M; Rouibah H; Zihlif M; Ahram M; Abu-Irmaileh B; Mustafa E; Al-Ameer HJ; Al Shhab M
Anticancer Agents Med Chem; 2018; 18(9):1330-1337. PubMed ID: 30088453
[TBL] [Abstract][Full Text] [Related]
18. Multidrug-resistant cancer cells are preferential targets of the new antineoplastic lanthanum compound KP772 (FFC24).
Heffeter P; Jakupec MA; Körner W; Chiba P; Pirker C; Dornetshuber R; Elbling L; Sutterlüty H; Micksche M; Keppler BK; Berger W
Biochem Pharmacol; 2007 Jun; 73(12):1873-86. PubMed ID: 17445775
[TBL] [Abstract][Full Text] [Related]
19. Organosilicon Compounds, SILA-409 and SILA-421, as Doxorubicin Resistance-Reversing Agents in Human Colon Cancer Cells.
Wesołowska O; Michalak K; Błaszczyk M; Molnár J; Środa-Pomianek K
Molecules; 2020 Apr; 25(7):. PubMed ID: 32260260
[TBL] [Abstract][Full Text] [Related]
20. Design and synthesis of new potent N,N-bis(arylalkyl)piperazine derivatives as multidrug resistance (MDR) reversing agents.
Dei S; Coronnello M; Bartolucci G; Manetti D; Romanelli MN; Udomtanakunchai C; Salerno M; Teodori E
Eur J Med Chem; 2018 Mar; 147():7-20. PubMed ID: 29421572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
